---
title: "Request for Information - Oligonucleotides Onshoring"
ocid: "ocds-h6vhtk-06b480"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-06b480"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-06b480.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-06b480.json"
source: "Find A Tender Service"
current_stage: "Planning"
buyer: "SECRETARY OF STATE FOR HEALTH AND SOCIAL CARE ACTING AS PART OF THE CROWN THROUGH UK HEALTH SECURITY AGENCY"
published: "2026-06-12"
---

# Request for Information - Oligonucleotides Onshoring

Buyer: SECRETARY OF STATE FOR HEALTH AND SOCIAL CARE ACTING AS PART OF THE CROWN THROUGH UK HEALTH SECURITY AGENCY  
Current stage: Planning  
OCID: ocds-h6vhtk-06b480

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-06b480)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-06b480.json)

## Summary

The UK Health Security Agency, acting through the Secretary of State for Health and Social Care, is currently in the planning stage of a procurement process titled "Request for Information – Oligonucleotides Onshoring." This process is focused on enhancing biosecurity and resilience in the UK by potentially increasing oligonucleotide manufacturing capabilities. The procurement, classified under laboratory reagents, is situated in the United Kingdom with a central office at 10 South Colonnade, London. A key milestone includes a scheduled Request for Information due date on 10th July 2026, providing businesses an opportunity to respond with relevant expertise. This advance engagement follows the legal framework outlined in UKPGA 2023/54 and aims to refine the procurement strategy ahead of the planned contract period from April 2027 to April 2030.

This tender presents significant opportunities for businesses involved in the manufacturing of oligonucleotides. Companies that can offer innovative solutions or enhanced production capabilities are well-positioned to support the UK's efforts to improve its biosecurity infrastructure. The UK Health Security Agency is particularly interested in engaging with small and medium-sized enterprises (SMEs) and voluntary, community, and social enterprises (VCSEs) to expand and solidify onshore production capacities. Businesses that participate in the RFI process can help shape the future landscape of oligonucleotide supply, potentially leading to substantial growth opportunities in both the domestic and global markets.

## Notice

1. The purpose of this document is to enhance the Authority's understanding of the marketplace and its options for sourcing for a potential future requirement. 2. The issuance of this request for information (RFI) does not constitute a sourcing exercise nor will the Authority pay any costs incurred in the preparation of a response to this RFI. 3. The UK Health Security Agency's (UKHSA) key objectives for this RFI are: a. understand the ability of the marketplace to fulfil its requirements; b. refine the scope of the requirements to best align to the marketplace; and c. inform the Authority's chosen route to market to best enable competition 4. The key dates for this RFI are as follows: 1. RFI Published: 12th June 2026 2. RFI Response: 10th July 2026 Description of Scope of Requirements: The UK Health Security Agency (UKHSA) is responsible for protecting every member of every community from the impact of infectious diseases, chemical, biological, radiological and nuclear incidents and other health threats. We provide intellectual, scientific and operational leadership at national and local level, as well as on the global stage, to make the nation's health secure. UKHSA sees access to oligonucleotide manufacturers as key to increasing the UK's biosecurity, preparedness and resilience for infectious diseases. Oligonucleotides are a ubiquitous reagent used widely at many stages for research, development and use of diagnostics and countermeasures for infectious disease. Synthetic oligonucleotides are used widely as essential components of molecular diagnostic assays, sequencing methods and for development of serological assays, as well as critical reagents in the research, development and manufacture of new vaccines and therapeutics. The market for oligonucleotide supply in the UK, when you include use outside of infectious disease-related applications, is significant. UKHSA would like to understand the breadth and depth of oligonucleotide manufacturing capability in the UK and globally. This includes what oligonucleotides are already being manufactured, and to what design, what dependencies or bottlenecks exist, how these are being applied to make a product, and the existing and potential scale of manufacturing capacity. Although UKHSA is interested in understanding international manufacturing capability, UKHSA is specifically interested in improving onshore manufacturing capability for oligonucleotides and would encourage respondents to reflect any future intentions in the UK. This information will be used to inform UKHSA's future approach to improve access to oligonucleotide products, and engagement with oligonucleotide manufacturers about UKHSA's requirements. Should you wish to respond to this Request for Information, please complete the response questionnaire which is found at the following link: https://atamis-1928.my.salesforce-sites.com/ProSpend__CS_ContractPage?SearchType=Projects&uid=a07Pz00001dZ2lOIAS&searchStr=request+for+information&sortStr=Recently+Published&page=1&filters=&County=

### Planning Information

Request for Information

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/055938-2026 |
| Notice type | UK2 - Preliminary Market Engagement Notice |
| Procurement type | Standard |
| Procurement category | Goods |
| Procurement method | Not Specified |
| Procurement method details | Not specified |
| Tender suitability | SME, VCSE |
| Awardee scale | Not specified |
| All stages | Planning |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 12 Jun 2026 |
| Submission deadline | Not specified |
| Future notice date | 1 Dec 2026 |
| Award date | Not specified |
| Contract period | 31 Mar 2027 - 1 Apr 2030 |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | £1 |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | Not specified |

## Status

| Field | Value |
| --- | --- |
| Tender status | Planning |
| Lots status | Planning |
| Awards status | Not specified |
| Contracts status | Not specified |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | SECRETARY OF STATE FOR HEALTH AND SOCIAL CARE ACTING AS PART OF THE CROWN THROUGH UK HEALTH SECURITY AGENCY |
| Locality | LONDON |
| Post town | East London |
| Postcode | E14 4PU |
| Country | England |
| ITL 1 | TLI London |
| ITL 2 | TLI4 Inner London - East |
| ITL 3 | TLI42 Tower Hamlets |
| Local authority | Tower Hamlets |
| Electoral ward | Canary Wharf |
| Westminster constituency | Poplar and Limehouse |
| Delivery location | Not specified |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33696500 - Laboratory reagents

## Release History

- 12 Jun 2026 at 18:12 - Planning - UK2 - Preliminary Market Engagement Notice - https://www.find-tender.service.gov.uk/Notice/055938-2026

## Documents

- https://www.find-tender.service.gov.uk/Notice/055938-2026
  12th June 2026 - Preliminary market engagement notice on Find a Tender

## Notice URLs

- https://atamis-1928.my.salesforce-sites.com/ProSpend__CS_ContractPage?SearchType=Projects&uid=a07Pz00001dZ2lOIAS&searchStr=request+for+information&sortStr=Recently+Published&page=1&filters=&County=
- https://www.gov.uk/government/organisations/uk-health-security-agency
- https://www.legislation.gov.uk/ukpga/2023/54/contents

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-06b480. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-06b480.json.